药源性肺纤维化6例分析

摘要

目的：减少误诊率及不良反应。方法：回顾性分析2000-2013年笔者所在门诊部肺纤维化患者中明确病因的药源性肺纤维化6例治疗经过。结果：易瑞沙所致肺纤维化2例，乙胺碘呋酮引起肺纤维化2例，白消安导致肺纤维化1例，呋喃妥因引起肺纤维化1例。结论：作为基层门诊医生应提高对药源性肺纤维化的认识，减少不良反应的发生，以免给患者带来不必要的痛苦。%Objective:To reduce the rate of misdiagnosis and adverse reactions.Method:The treatment of drug-induced pulmonary fibrosis were analyzed retrospectively from 2000 to 2013(6 cases).Result:There were 2 cases caused by iressa,2 cases caused by amiodarone,1 case caused by busulfan,1 case caused by nitrofurantoin.Conclusion:The clinic doctor should raise awareness of drug-induced pulmonary fibrosis,to reduce the incidence of adverse reactions, so as not to cause unnecessary suffering to the patients.